RHYTHM PHARMACEUTICALS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $6.35M.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $180.00K, a 64.07% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $383.00K, a 120.11% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $501.00K, a 15.44% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $1.48M, a 5.50% decline from fiscal 2019.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $1.56M.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2018 was -$1.81M, a 358.29% decline from fiscal 2017.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2017 was $700.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-03-31 | $6.35M 10-Q · filed 2025-05-07 | |
| 2021-09-30 | $180.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $383.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $1.48M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $501.00K 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $174.00K 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $383.00K 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $1.56M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $434.00K 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $465.00K 10-Q · filed 2020-11-02 | |
| 2019-03-31 | $54.00K 10-Q · filed 2020-11-02 | |
| 2018-12-31 | -$1.81M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $1.24M 10-Q · filed 2019-11-01 | |
| 2018-06-30 | $399.00K 10-Q · filed 2019-11-01 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $700.00K 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |